234 related articles for article (PubMed ID: 10369486)
1. Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro.
Werthwein S; Bauer U; Nakazi M; Kathmann M; Schlicker E
Br J Pharmacol; 1999 May; 127(1):300-8. PubMed ID: 10369486
[TBL] [Abstract][Full Text] [Related]
2. Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors.
Schlicker E; Werthwein S; Kathmann M; Bauer U
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):418-22. PubMed ID: 9826063
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices.
Siniscalchi A; Rodi D; Beani L; Bianchi C
Br J Pharmacol; 1999 Sep; 128(1):119-23. PubMed ID: 10498842
[TBL] [Abstract][Full Text] [Related]
4. ORL1 receptor-mediated inhibition by nociceptin of noradrenaline release from perivascular sympathetic nerve endings of the rat tail artery.
Bucher B
Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):682-5. PubMed ID: 9879729
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors.
Nakazi M; Bauer U; Nickel T; Kathmann M; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):19-24. PubMed ID: 10651142
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.
Flau K; Redmer A; Liedtke S; Kathmann M; Schlicker E
Br J Pharmacol; 2002 Dec; 137(8):1355-61. PubMed ID: 12466246
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the ORL1 receptor-mediated inhibition of noradrenaline release in human and rat neocortical slices.
Rominger A; Förster S; Zentner J; Dooley DJ; McKnight AT; Feuerstein TJ; Jackisch R; Vlaskovska M
Br J Pharmacol; 2002 Feb; 135(3):800-6. PubMed ID: 11834628
[TBL] [Abstract][Full Text] [Related]
8. Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin.
Sbrenna S; Marti M; Morari M; Calo' G; Guerrini R; Beani L; Bianchi C
Br J Pharmacol; 2000 May; 130(2):425-33. PubMed ID: 10807682
[TBL] [Abstract][Full Text] [Related]
9. Mutual interactions of the presynaptic histamine H3 and prostaglandin EP3 receptors on the noradrenergic terminals in the mouse brain.
Schlicker E; Marr I
Neuroscience; 1997 Jul; 79(1):247-54. PubMed ID: 9178880
[TBL] [Abstract][Full Text] [Related]
10. The stereoselective kappa-opioid receptor antagonist Mr 2266 does not exhibit stereoselectivity as an antagonist at the orphan opioid (ORL1) receptor.
Bauer U; Nakazi M; Kathmann M; Göthert M; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):17-20. PubMed ID: 9933145
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex.
Berger B; Rothmaier AK; Wedekind F; Zentner J; Feuerstein TJ; Jackisch R
Br J Pharmacol; 2006 Jul; 148(6):795-806. PubMed ID: 16751796
[TBL] [Abstract][Full Text] [Related]
12. Nociceptin inhibits the neurogenic vasopressor response in the pithed rat via prejunctional ORL1 receptors.
Malinowska B; Kozłowska H; Koneczny B; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):80-4. PubMed ID: 10651151
[TBL] [Abstract][Full Text] [Related]
13. H2 receptor-mediated facilitation and H3 receptor-mediated inhibition of noradrenaline release in the guinea-pig brain.
Timm J; Marr I; Werthwein S; Elz S; Schunack W; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):232-9. PubMed ID: 9550293
[TBL] [Abstract][Full Text] [Related]
14. Characterization of specific [3H]nociceptin binding in rat brain and spinal cord.
Kusaka T; Yamada S; Kimura R
Biol Pharm Bull; 2001 Aug; 24(8):902-5. PubMed ID: 11510482
[TBL] [Abstract][Full Text] [Related]
15. Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro.
Siniscalchi A; Rodi D; Morari M; Marti M; Cavallini S; Marino S; Beani L; Bianchi C
Br J Pharmacol; 2002 Aug; 136(8):1178-84. PubMed ID: 12163351
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain.
Kathmann M; Bauer U; Schlicker E; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):466-70. PubMed ID: 10431757
[TBL] [Abstract][Full Text] [Related]
17. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of serotonin release in the rat brain cortex by activation of ionotropic glutamate receptors and its modulation via alpha 2-heteroreceptors.
Fink K; Schmitz V; Böing C; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):394-401. PubMed ID: 8532067
[TBL] [Abstract][Full Text] [Related]
19. Modulation of N-methyl-D-aspartate (NMDA)-stimulated noradrenaline release in rat brain cortex by presynaptic alpha 2-adrenoceptors.
Fink K; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):372-8. PubMed ID: 7904051
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta.
Schultheiss T; Flau K; Kathmann M; Göthert M; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):139-46. PubMed ID: 16195872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
